Quick Answer
TELA Bio, Inc. reported R&D Expense of $9.22 million for fiscal year 2025.
TELA Bio, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $9.22M | +4.6% |
| 2024 | $8.81M | -8.4% |
| 2023 | $9.62M | +7.6% |
| 2022 | $8.94M | +32.5% |
| 2021 | $6.74M | +58.5% |
| 2020 | $4.25M | +2.5% |
| 2019 | $4.15M | -4.3% |
| 2018 | $4.34M | -25.0% |
| 2017 | $5.79M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.35M | +13.5% | +6.6% |
| June 30, 2025 | $2.20M | -5.2% | -13.3% |
| March 31, 2025 | $2.54M | +6.1% | +22.8% |
| September 30, 2024 | $2.07M | -12.7% | -11.0% |
| June 30, 2024 | $2.32M | -7.6% | -2.9% |
| March 31, 2024 | $2.39M | +16.6% | +1.1% |
| September 30, 2023 | $2.37M | +12.7% | -5.8% |
| June 30, 2023 | $2.51M | +19.6% | +22.5% |
- TELA Bio, Inc. showed an increase of +4.6% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2025 period, TELA Bio, Inc.’s r&d expense has grown by 59.4% (from $5.79 million to $9.22 million).
- The most recent figure is from TELA Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: